Correction (DOI:10.1016/j.jamcollsurg.2009.07.006);Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment

Journal of the American College of Surgeons

Volumn 209, Issue 4, 2009, Pages 504-520

  Silverstein, Melvin J ^a   Recht, Abram ^a   Lagios, Michael D ^a   Bleiweiss, Ira J ^a   Blumencranz, Peter W ^a   Gizienski, Terri ^a   Harms, Steven E ^a   Harness, Jay ^a   Jackman, Roger J ^a   Klimberg, V Suzanne ^a   Kuske, Robert ^a   Levine, Gary M ^a   Linver, Michael N ^a   Rafferty, Elizabeth A ^a   Rugo, Hope ^a   Schilling, Kathy ^a   Tripathy, Debu ^a   Whitworth, Pat W ^a   Willey, Shawna C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB; TUMOR MARKER; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; HER2 PROTEIN, HUMAN;

ACCELERATED PARTIAL BREAST IRRADIATION; ARTICLE; BRACHYTHERAPY; BREAST BIOPSY; BREAST CANCER; CANCER INVASION; CARDIOTOXICITY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; ECHOMAMMOGRAPHY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; HOT FLUSH; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PARTIAL MASTECTOMY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; TREATMENT INDICATION; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT; VAGINAL DRYNESS; VENOUS THROMBOEMBOLISM; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BIOPSY; BREAST RECONSTRUCTION; BREAST TUMOR; CHEMISTRY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; ECONOMICS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEALTH CARE COST; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; MINIMALLY INVASIVE SURGERY; PALPATION; PATHOLOGY; SEGMENTAL MASTECTOMY; UNITED STATES;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEALTH CARE COSTS; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMAPLASTY; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY, SEGMENTAL; PALPATION; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECEPTOR, ERBB-2; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SPECIMEN HANDLING; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, MAMMARY; UNITED STATES;

EID: 70349419536     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.10.002     Document Type: Erratum

References (25)

1. International Breast Cancer Consensus Conference. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 193 (2001) 297-302
2. Silverstein M.J., Lagios M.D., Recht A., et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 201 (2005) 586-597
3. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353 (2005) 1773-1783
4. American College of Radiology. BI-RADS® - Ultrasound, first edition (2003). http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BIRADSAtlas/BIRADSAtlasexcerptedtext/BIRADSUltrasoundFirstEdition.aspx Accessed June 13, 2009
5. Berg W.A., Blume J.D., Cormack J.B., et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299 (2008) 2151-2163
6. Drew P., Turnbull L., Harvey I., et al. MR imaging in breast cancer - results of the COMICE trial (abstract 5). Eur J Surg Oncol 34 (2008) 1156
7. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
8. American College of Radiology. ACR practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast (2008). http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast/mri_breast.aspx Accessed July 5, 2009
9. American College of Radiology. BI-RADS® - MRI, first edition (2003). http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BIRADSAtlas/BIRADSAtlasexcerptedtext/BIRADSMRIFirstEdition.aspx Accessed June 13, 2009
10. Consensus Conference Committee. Consensus conference on the classification of ductal carcinoma in situ. Cancer 80 (1997) 1798-1802
11. Lester S.C., Bose S., Chen Y.Y., et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 133 (2009) 15-25
12. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
13. Tjan-Heijnen V.C., Pepels M.J., de Boer M., et al. Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i+]) in the sentinel lymph node (SN): Results from the MIRROR study (abstract CRA506). J Clin Oncol 27 (2009) 803s
14. Viani G.A., Stefano E.J., Afonso S.L., et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol 2 (2007) 28
15. National Comprehensive Cancer Network. Breast cancer - v.1.2009 (2009). http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf Accessed July 5, 2009
16. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
17. Polgár C., Fodor J., Major T., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007) 694-702
18. Keisch M, Arthur D, Patel R, et al. American Brachytherapy Society Breast Brachytherapy Task Group. 2007. Available at: www.americanbrachytherapy.org/.../abs_breast_brachytherapy_taskgroup.pdf. Accessed July 4, 2009.
19. American Society of Breast Surgeons. Consensus statement for accelerated partial breast irradiation (2008). http://www.breastsurgeons.org/statements/index.php/APBI_statement_revised_10/07/08.pdf Accessed July 4, 2009
20. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74 (2009) 987-1001
21. Sparano J.A., and Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 26 (2008) 721-728
22. Cardoso F., Van't Veer L., Rutgers E., et al. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol 26 (2008) 729-735
23. Winer E.P., Hudis C., Burstein H.J., et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23 (2005) 619-629
24. Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009. Ann Oncol 2009, Advance Access published on June 17, 2009; doi:10.1093/annonc/mdp322. PMID 19535820.
25. Drug interactions with Tamoxifen. http://www.medicine.iupui.edu/clinpharm/COBRA/TamoxifenGuide.pdf Accessed July 29, 2009